We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
(+9%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$28.3M |
| 2 |
Allstate
ALL
|
+$25.8M |
| 3 |
Intuitive Surgical
ISRG
|
+$19.6M |
| 4 |
Neogen
NEOG
|
+$17.4M |
| 5 |
DoubleVerify
DV
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$29.1M |
| 2 |
Planet Fitness
PLNT
|
+$20.4M |
| 3 |
Airbnb
ABNB
|
+$17.1M |
| 4 |
IBM
IBM
|
+$14.8M |
| 5 |
Xometry
XMTR
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 18.44% |
| 3 | Industrials | 11.64% |
| 4 | Financials | 11.51% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Power Integrations
POWI
$3.54B
| $315K | ﹤0.01% |
+3,325
| New | +$278K |
|
1227
Perrigo
PRGO
$1.74B
| $314K | ﹤0.01% |
9,249
-1,009
| -10% | -$35K |
|
1228
Varonis Systems
VRNS
$4.97B
| $313K | ﹤0.01% |
11,748
-5,522
| -32% | -$138K |
|
1229
ProShares Ultra Financials
UYG
$856M
| $313K | ﹤0.01% |
6,855
| – | – |
|
1230
Allegion
ALLE
$13.9B
| $311K | ﹤0.01% |
2,593
+33
| +1% | +$3.6K |
|
1231
iShares US Small Cap Equity Factor ETF
SMLF
$4.31B
| $311K | ﹤0.01% |
+5,804
| New | +$295K |
|
1232
W.R. Berkley
WRB
$25.9B
| $311K | ﹤0.01% |
7,835
+342
| +5% | +$13.4K |
|
|
GGT
1233
Gabelli Multimedia Trust
GGT
$175M
| $311K | ﹤0.01% |
48,001
-33,186
| -41% | -$195K |
|
1234
Beyond Meat
BYND
$216M
| $311K | ﹤0.01% |
23,951
-3,508
| -13% | -$44.5K |
|
1235
AES
AES
$10.5B
| $311K | ﹤0.01% |
14,996
-2,203
| -13% | -$48.5K |
|
1236
iShares US Consumer Staples ETF
IYK
$1.43B
| $309K | ﹤0.01% |
4,632
| – | – |
|
1237
iShares MBS ETF
MBB
$39.2B
| $309K | ﹤0.01% |
3,309
-358
| -10% | -$33.7K |
|
1238
Amdocs
DOX
$6.08B
| $308K | ﹤0.01% |
3,119
| – | – |
|
1239
iShares Silver Trust
SLV
$31.4B
| $308K | ﹤0.01% |
14,732
-3,481
| -19% | -$77.4K |
|
1240
NovoCure
NVCR
$2.04B
| $307K | ﹤0.01% |
7,406
+906
| +14% | +$56.3K |
|
1241
Hertz
HTZ
$927M
| $305K | ﹤0.01% |
16,587
+4,439
| +37% | +$72.7K |
|
1242
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
| $305K | ﹤0.01% |
7,970
+36
| +0.5% | +$1.38K |
|
1243
P3 Health Partners
PIII
$36.2M
| $303K | ﹤0.01% |
2,027
| – | – |
|
1244
Health Catalyst
HCAT
$134M
| $303K | ﹤0.01% |
+24,200
| New | +$288K |
|
1245
PVH
PVH
$3.79B
| $302K | ﹤0.01% |
3,552
-1
| -0% | -$84 |
|
1246
Western Union
WU
$2.27B
| $300K | ﹤0.01% |
25,598
-782
| -3% | -$9.01K |
|
1247
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.17B
| $297K | ﹤0.01% |
4,875
-537
| -10% | -$30.8K |
|
1248
iShares Global Healthcare ETF
IXJ
$4.23B
| $295K | ﹤0.01% |
3,476
+220
| +7% | +$18.8K |
|
1249
Western Midstream Partners
WES
$20.1B
| $294K | ﹤0.01% |
11,104
-1,394
| -11% | -$36.7K |
|
1250
Arch Capital
ACGL
$33.2B
| $294K | ﹤0.01% |
3,924
+101
| +3% | +$7.3K |
|
Similar funds
HF
William Blair & Company's Q2 2023 Portfolio in Review
As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
- William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
- William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
- William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
- William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
- William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
- William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.
Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.